What medications are used to treat fibromyalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Fibromyalgia Treatment

The most effective FDA-approved medications for fibromyalgia are pregabalin, duloxetine, and milnacipran, with pregabalin being the first drug specifically approved for fibromyalgia management. 1, 2

First-Line Pharmacological Options

  • Pregabalin (300-450 mg/day) is FDA-approved for fibromyalgia and effectively reduces pain and improves sleep quality (Level Ia, Grade A evidence) 1, 2
  • Duloxetine (60 mg/day) is recommended for pain reduction, functional improvement, and associated depression (Level Ia, Grade A evidence) 1
  • Milnacipran (100-200 mg/day) is effective for pain reduction and fatigue symptoms (Level Ia, Grade A evidence) 1
  • Amitriptyline (10-75 mg/day) is recommended for pain reduction and improved function, particularly beneficial for patients with sleep disturbances due to its sedating properties (Level Ia, Grade A evidence) 1

Medication Administration and Titration

  • For pregabalin, start with low doses (25-50 mg at night) and gradually increase to minimize side effects such as dizziness, somnolence, and cognitive dysfunction 3
  • Divide pregabalin's daily dose into two or three equal doses to improve tolerability 2, 3
  • Monitor for dose-related side effects including weight gain and peripheral edema with pregabalin 3
  • For amitriptyline, start with 10 mg at bedtime and gradually increase to 25-50 mg as tolerated 1, 4

Medication Efficacy and Expectations

  • Pregabalin demonstrates multidimensional effects in fibromyalgia, with rapid and clinically significant improvements in pain and sleep 5
  • Only about 50% of patients with fibromyalgia will respond adequately to pregabalin at approved dosages 6
  • Most patients remain on the same dose throughout treatment, with >60% not requiring dose increases 7
  • Treatment durability has been demonstrated for at least 6 months in pregabalin responders 6

Treatment Continuation and Adherence

  • Only about one-fifth of patients continue their initially prescribed medication (amitriptyline, duloxetine, gabapentin, or pregabalin) for ≥1 year 7
  • Pregabalin should be discontinued gradually to avoid withdrawal symptoms 3
  • Regular reassessment of pain levels, function, and side effects is essential to evaluate treatment efficacy 1

Important Precautions and Monitoring

  • Monitor pregabalin-treated patients for emergence or worsening of depression and suicidal thoughts 3
  • Pregabalin can be safely combined with other medications due to its lack of protein binding and negligible hepatic metabolism 3
  • Use caution when combining pregabalin with central nervous system depressants as it may worsen sedation 3
  • Adjust pregabalin dosage in patients with renal insufficiency 1

Medications to Avoid

  • Corticosteroids are not recommended for fibromyalgia treatment 1, 4
  • Strong opioids have not demonstrated benefits for fibromyalgia and are not recommended 1, 4
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) have not shown significant benefits for fibromyalgia 4

Comprehensive Treatment Approach

  • Medications should be used as part of a broader treatment approach that includes non-pharmacological interventions 1
  • Aerobic and strengthening exercise has the strongest evidence (Level Ia, Grade A) and should be implemented alongside medication therapy 1
  • Cognitive behavioral therapy is particularly beneficial for patients with concurrent mood disorders 1
  • Patient education about the chronic nature of fibromyalgia is crucial for setting realistic expectations 1

References

Guideline

Treatment for Fibromyalgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregabalin for the management of fibromyalgia syndrome.

Journal of pain research, 2010

Research

Fibromyalgia: Diagnosis and Management.

American family physician, 2023

Research

Pregabalin for the treatment of fibromyalgia.

Expert opinion on pharmacotherapy, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.